FDA OK's New Cholesterol Drug

]]>(MedPage Today) -- WASHINGTON--It's a green light for bempedoic acid (Nexletol): FDA approved the once-daily oral pill for low-density lipoprotein (LDL) cholesterol lowering as an adjunct to maximally tolerated statin therapy, the agency announced...